Small-molecule CEM3 strengthens single-cell oscillators in the suprachiasmatic nucleus

被引:0
|
作者
van Beurden, Anouk W. [1 ]
Tersteeg, Mayke M. H. [1 ]
Michel, Stephan [1 ]
van Veldhoven, Jaco P. D. [2 ]
Ijzerman, Adriaan P. [2 ]
Rohling, Jos H. T. [1 ]
Meijer, Johanna H. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands
[2] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
来源
FASEB JOURNAL | 2024年 / 38卷 / 01期
基金
欧洲研究理事会;
关键词
CEM3; PER2; rhythm amplitude; small molecule; suprachiasmatic nucleus; synchrony; CIRCADIAN-RHYTHMS; CLOCK; MODULATORS; NEURONS; MOUSE;
D O I
10.1096/fj.202300597RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A robust endogenous clock is required for proper function of many physiological processes. The suprachiasmatic nucleus (SCN) constitutes our central circadian clock and allows us to adapt to daily changes in the environment. Aging can cause a decline in the amplitude of circadian rhythms in SCN and peripheral clocks, which contributes to increased risk of several chronic diseases. Strengthening clock function would therefore be an effective strategy to improve health. A high-throughput chemical screening has identified clock-enhancing molecule 3 (CEM3) as small molecule that increases circadian rhythm amplitude in cell lines and SCN explants. It is, however, currently not known whether CEM3 acts by enhancing the amplitude of individual single-cell oscillators or by enhancing synchrony among neurons. In view of CEM3's potential, it is of evident importance to clarify the mode of action of CEM3. Here, we investigated the effects of CEM3 on single-cell PERIOD2::LUCIFERASE rhythms in mouse SCN explants. CEM3 increased the amplitude in approximately 80%-90% of the individual cells in the SCN without disrupting the phase and/or period of their rhythms. Noticeably, CEM3's effect on amplitude is independent of the cell's initial amplitude. These findings make CEM3 a potential therapeutic candidate to restore compromised amplitude in circadian rhythms and will boost the development of other molecular approaches to improve health. Circadian rhythms are generated by the suprachiasmatic nucleus (SCN). Disruption of rhythms is a causal risk factor for the development of diseases, like depression or immune disorders. The small-molecule CEM3 strengthens SCN rhythms by enhancement of amplitude. We asked whether amplitude enhancement is a single-cell or a network phenomenon. The results indicate that CEM3 operates by increasing the amplitude of individual SCN neurons. This makes CEM3 an interesting therapeutic candidate for improving health by strengthening our internal clock.image
引用
收藏
页数:12
相关论文
共 50 条
  • [41] A 2-(trifluoromethyl)thieno [3,4-b]thiophene-based small-molecule electron acceptor for polymer solar cell application
    Wang, Pengfei
    Fan, Haijun
    Zhu, Xiaozhang
    DYES AND PIGMENTS, 2018, 155 : 179 - 185
  • [42] Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth
    Sayyah, Jacqueline
    Magis, Andrew
    Ostrov, David A.
    Allan, Robert W.
    Braylan, Raul C.
    Sayeski, Peter P.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2308 - 2318
  • [43] Evaluating the Genotoxicity of Small-Molecule Nitrosamines and Nitrosamine Drug Substance-Related Impurities in 2D and 3D HepaRG Cell Models
    Xu, Hannah
    Seo, Ji-Eun
    Li, Xilin
    Mei, Nan
    Heflich, Robert
    Atrakchi, Aisar H.
    McGovern, Timothy J.
    Bruno, Karen L. Davis
    Guo, Xiaoqing
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2024, 65 : 109 - 110
  • [44] Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
    Leverson, J. D.
    Zhang, H.
    Chen, J.
    Tahir, S. K.
    Phillips, D. C.
    Xue, J.
    Nimmer, P.
    Jin, S.
    Smith, M.
    Xiao, Y.
    Kovar, P.
    Tanaka, A.
    Bruncko, M.
    Sheppard, G. S.
    Wang, L.
    Gierke, S.
    Kategaya, L.
    Anderson, D. J.
    Wong, C.
    Eastham-Anderson, J.
    Ludlam, M. J. C.
    Sampath, D.
    Fairbrother, W. J.
    Wertz, I.
    Rosenberg, S. H.
    Tse, C.
    Elmore, S. W.
    Souers, A. J.
    CELL DEATH & DISEASE, 2015, 6 : e1590 - e1590
  • [45] Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
    J D Leverson
    H Zhang
    J Chen
    S K Tahir
    D C Phillips
    J Xue
    P Nimmer
    S Jin
    M Smith
    Y Xiao
    P Kovar
    A Tanaka
    M Bruncko
    G S Sheppard
    L Wang
    S Gierke
    L Kategaya
    D J Anderson
    C Wong
    J Eastham-Anderson
    M J C Ludlam
    D Sampath
    W J Fairbrother
    I Wertz
    S H Rosenberg
    C Tse
    S W Elmore
    A J Souers
    Cell Death & Disease, 2015, 6 : e1590 - e1590
  • [46] Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule
    Lawal, Bashir
    Wu, Alexander T. H.
    Huang, Hsu-Shan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Four-level Nonvolatile Small-molecule Memory-cell Embedded with Fe Nanocrystals Surrounded with an FeO and Fe2O3 Tunneling Barrier
    Seo, Sung-Ho
    Nam, Woo-Sik
    Park, Kwang-Hee
    Park, Jea-Gun
    JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2010, 57 (06) : 1426 - 1431
  • [48] A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer
    Wang, Jin
    Wang, Hong-Ying
    Shen, Ying
    Liang, Dong
    Wang, Hui-Yan
    Zhang, San-Qi
    Cao, Yong-Xiao
    Cao, Lei
    ANTI-CANCER DRUGS, 2019, 30 (09) : 900 - 908
  • [49] Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin Receptor
    Wu, Zining
    Graybill, Todd L.
    Zeng, Xin
    Platchek, Michael
    Zhang, Jean
    Bodmer, Vera Q.
    Wisnoski, David D.
    Deng, Jianghe
    Coppo, Frank T.
    Yao, Gang
    Tamburino, Alex
    Scavello, Genaro
    Franklin, G. Joseph
    Mataruse, Sibongile
    Bedard, Katie L.
    Ding, Yun
    Chai, Jing
    Summerfield, Jennifer
    Centrella, Paolo A.
    Messer, Jeffrey A.
    Pope, Andrew J.
    Israel, David I.
    ACS COMBINATORIAL SCIENCE, 2015, 17 (12) : 722 - 731
  • [50] A small-molecule antagonist of CXCR1 and CXCR2 inhibits cell proliferation, migration and invasion in melanoma via PI3K/AKT pathway
    Shang, Fu-min
    Li, Jing
    MEDICINA CLINICA, 2019, 152 (11): : 425 - 430